Skip to Content

GG 739 (DICLOFENAC 75 mg)

Pill imprint GG 739 has been identified as Diclofenac sodium delayed release 75 mg.

Diclofenac is used in the treatment of back pain; pain; frozen shoulder; ankylosing spondylitis; muscle pain (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. There is positive evidence of human fetal risk during pregnancy. Diclofenac 75 mg is not subject to the Controlled Substances Act.

See also related documents.

Diclofenac sodium delayed release 75 mg GG 739  Front
Diclofenac sodium delayed release 75 mg GG 739  Back
Diclofenac sodium delayed release
GG 739
75 mg
10.00 mm
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
carnauba wax
microcrystalline cellulose
croscarmellose sodium
ferric oxide red
ferric oxide yellow
ferrosoferric oxide
glyceryl monostearate
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-4166 A-S Medication Solutions, LLC (repackager)
66267-0071 Nucare Pharmaceuticals Inc (repackager)
55289-0150 PDRX Pharmaceuticals Inc (repackager)
18837-0041 Innoviant Pharmacy Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.